Live
FierceBiotechThermo Fisher sees higher Q1 earnings amid strong biopharma demandThermo FisherCalamos Advisors LLC Raises Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat10x Genomics Blog10x Genomics Stock Falls 5.4% After Thermo Fisher Q1 Miss Signals Life Sciences Slowdown - News and Statistics - IndexBoxCellA skin-hypothalamus axis couples heat stress and metabolic dysfunctionCellThe evolution of high-order genome architecture revealed from 1,000 speciesCellSomatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative statesCellPyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylationCellMechanism-guided identification of antidepressant G protein-coupled receptor drug targetsThermo FisherThermo Fisher Raises Outlook As Clario Deal Deepens AI Trial Capabilities - simplywall.stBDArea Softball: PRB gets 2 wins - Brainerd DispatchFierceBiotechWCG acquires The Contract Network in bid to streamline clinical trial executionRecursionRecursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com Canada
FierceBiotech Apr 25, 2026

Thermo Fisher sees higher Q1 earnings amid strong biopharma demand

Thermo Fisher sees higher Q1 earnings amid strong biopharma demand

Body unavailable. Use the original source.